The majority of clinical commissioning groups (CCG), including medicine management teams, are represented on wider Area Prescribing Committees (APCs). APCs work to support clinicians across their geographical area with evidence-based and cost effective prescribing decisions. CCGs will scrutinise decisions in different ways in accordance with their own governance arrangements.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"} } , "answeringMemberConstituency" : {"_value" : "Warrington South"} , "answeringMemberPrinted" : {"_value" : "David Mowat"} , "dateOfAnswer" : {"_value" : "2016-11-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-04T14:42:58.99Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-10-31", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Clinical Commissioning Groups: Accountability"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what accountability mechanisms are in place for the scrutiny of decisions made by a clinical commissioning group's medicine management team.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4027", "label" : {"_value" : "Biography information for Baroness Morgan of Cotes"} } , "tablingMemberConstituency" : {"_value" : "Loughborough"} , "tablingMemberPrinted" : [{"_value" : "Nicky Morgan"} ], "uin" : "50972"} , {"_about" : "http://data.parliament.uk/resources/623426", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/623426/answer", "answerText" : {"_value" : "
Clinical commissioning groups (CCGs) are responsible for decisions on commissioning health services to best meet the needs of their local population and are accountable for local prescribing policy decisions. In commissioning services CCGs will reflect the needs of local people and support improvements in health and healthcare outcomes.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"} } , "answeringMemberConstituency" : {"_value" : "Warrington South"} , "answeringMemberPrinted" : {"_value" : "David Mowat"} , "dateOfAnswer" : {"_value" : "2016-11-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-11-04T14:47:20.323Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-10-28", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prescriptions"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what information his Department holds on the number of clinical commissioning groups that have undertaken an equality impact assessment before making changes to their prescription policy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4027", "label" : {"_value" : "Biography information for Baroness Morgan of Cotes"} } , "tablingMemberConstituency" : {"_value" : "Loughborough"} , "tablingMemberPrinted" : [{"_value" : "Nicky Morgan"} ], "uin" : "50904"} , {"_about" : "http://data.parliament.uk/resources/601095", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/601095/answer", "answerText" : {"_value" : "
The Department has received a small number of letters about the availability of injectable B12 over the counter and the issue was also raised at a meeting between the B12 Deficiency Group and the then Parliamentary Under-Secretary of State for Public Health (Jane Ellison) in July 2016. All authorised medicines for injection are classified by the Medicines and Healthcare products Regulatory Agency as prescription only. Whether or not a patient could self-administer a prescribed medicine would be a matter of clinical judgement for the patient\u2019s doctor to determine.<\/p>
The diagnosis and treatment for B12 deficiencies is well established and reported in the British Committee for Standards in Haematology (BCSH) guidance document, Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders<\/em>. The guidance was last updated in May 2014 and can be found at the following link:<\/p>